Abstract
The scientific challenges facing HIV-1 vaccine development are unprecedented in the history of vaccinology. As a result, investigators, funders, and other stakeholders generally agree that “game-changing” ideas are required. While innovation can certainly arise from investigators at all career stages, young and early-career investigators, defined as those under 40 years of age or within 10 years of their final degree or clinical training, are especially key contributors of novel and transformative ideas. Young and early-career investigators bring energy, enthusiasm, and fresh perspectives that are unbiased by prevailing dogma and that are essential to scientific progress.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Frahm, N., Rabadan, R., Fuchs, J. et al. Young and Early Career Investigators: Report from a Global HIV Vaccine Enterprise Working Group. Nat Prec (2010). https://doi.org/10.1038/npre.2010.4800.2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/npre.2010.4800.2
Keywords
This article is cited by
-
Link the world's best investigators
Nature (2013)